Correlation Between IVERIC Bio and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both IVERIC Bio and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IVERIC Bio and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IVERIC Bio and Travere Therapeutics, you can compare the effects of market volatilities on IVERIC Bio and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IVERIC Bio with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of IVERIC Bio and Travere Therapeutics.
Diversification Opportunities for IVERIC Bio and Travere Therapeutics
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between IVERIC and Travere is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding IVERIC Bio and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and IVERIC Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IVERIC Bio are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of IVERIC Bio i.e., IVERIC Bio and Travere Therapeutics go up and down completely randomly.
Pair Corralation between IVERIC Bio and Travere Therapeutics
If you would invest 1,776 in Travere Therapeutics on August 31, 2024 and sell it today you would earn a total of 94.00 from holding Travere Therapeutics or generate 5.29% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 4.55% |
Values | Daily Returns |
IVERIC Bio vs. Travere Therapeutics
Performance |
Timeline |
IVERIC Bio |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Travere Therapeutics |
IVERIC Bio and Travere Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with IVERIC Bio and Travere Therapeutics
The main advantage of trading using opposite IVERIC Bio and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IVERIC Bio position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.IVERIC Bio vs. Blueprint Medicines Corp | IVERIC Bio vs. Amylyx Pharmaceuticals | IVERIC Bio vs. Day One Biopharmaceuticals | IVERIC Bio vs. Immunovant |
Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies |